SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas.

Zhu, Eliot Y; Riordan, Jesse D; Vanneste, Marion; Henry, Michael D; Stipp, Christopher S; Dupuy, Adam J

Zhu, Eliot Y; Riordan, Jesse D; Vanneste, Marion; Henry, Michael D; Stipp, Christopher S; Dupuy, Adam J.

Afiliación

Zhu EY; Department of Anatomy and Cell Biology, The University of Iowa, Iowa City, IA, USA.
Riordan JD; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA.
Vanneste M; Cancer Biology Graduate Program, The University of Iowa, Iowa City, IA, USA.
Henry MD; The Medical Scientist Training Program, The University of Iowa, Iowa City, IA, USA.
Stipp CS; Department of Anatomy and Cell Biology, The University of Iowa, Iowa City, IA, USA.
Dupuy AJ; Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, USA.

NPJ Precis Oncol ; 6(1): 74, 2022 Oct 21.

Article en En | MEDLINE | ID: mdl-36271142

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google